A STUDY ON THE PREVALENCE OF SMALL FIBRE NEUROPATHY USING TORONTO CLINICAL NEUROPATHY SCORE IN DIABETICS
Main Article Content
Keywords
Diabetes, Nerve Conduction, Neuropathy, Small Fibre, TCNS.
Abstract
Introduction: Numerous vascular & non-vascular problems are linked to diabetes, a metabolic disease that is not communicable. Small fibre neuropathy arises from the targeted injury of the slender fibres within the peripheral nerve. the present study was conducted to study prevalence of small fibre neuropathy by using Toronto clinical neuropathy scale in diabetic population.
Material & Methods: The prospective, cross-sectional study was conducted among 151 patients with reports of blood sugars in diabetic range from January 2023 to June 2023 in Department of General Medicine, at Apollo Institute of Medical Sciences & Research, Hyderabad. Toronto Clinical Neuropathy score will be recorded for each patient. Results were analyzed using SPSS version 25.0.
Results: Maximum patients were in the age group of 51-60 years (27.8%) & least were in the group of 81-90 yeas (1.3%). Out of 151 patients 56.3% were male & 43.7% were female. The mean duration of diabetes was 7.2±2.3 years, mean FBS was 157.49±23.1 mg/dl, mean PLBS was 270.42±31.5, mean HbA1C was 8.84±1.2 % & 71.5% of patients had symptoms of disease. The mean TCNS score was 3.64±0.78. Out of 151 patients 102 (67.5%) were without DPN, 39 (25.8%) had mild DPN & 10 (6.62%) had moderate DPN. The duration of diabetes showed significant relationship (p=0.000) with the severity of diabetic neuropathy.
Conclusion: TCNS is a sensitive scoring system employed for the diagnosis of diabetic neuropathy & serves as a cost-effective bedside screening instrument.
References
[2] Singh G, Chawla S. Amputation in diabetic patients. Medical Journal Armed Forces India 2006;62(1):36-39.
[3] Ashok S, Ramu M, Deepa R, Mohan V. Prevalence of neuropathy in type 2 diabetic patients attending a diabetes centre in South India. J Assoc Physicians India 2002;50(4):546-50.
[4] Jacobs JM, Love S. Qualitative & quantitative morphology of human sural nerve at different ages. Brain 1985;108(4):897-924.
[5] Malik RA, Tesfaye S, Newrick PG, Walker D, Rajbhandari SM, Siddique I, et al. Sural nerve pathology in diabetic patients with minimal but progressive neuropathy. Diabetologia 2005;48:578-85.
[6] Said G, Baudoin D, Toyooka K. Sensory loss, pains, motor deficit & axonal regeneration in length-dependent diabetic polyneuropathy. Journal of Neurology 2008;255:1693-702.
[7] Bakkers M, Faber CG, Hoeijmakers JG, Lauria G, Merkies IS. Small fibers, large impact: quality of life in small fiber neuropathy. Muscle & Nerve 2014;49(3):329-36.
[8] Terkelsen AJ, Karlsson P, Lauria G, Freeman R, Finnerup NB, Jensen TS. The diagnostic challenge of small fibre neuropathy: clinical presentations, evaluations, & causes. The Lancet Neurology 2017;16(11):934-44.
[9] Levine TD. Small fiber neuropathy: disease classification beyond pain & burning. Journal of Central Nervous System Disease 2018;10:1179573518771703.
[10] Al-Geffari M. Comparison of different screening tests for diagnosis of diabetic peripheral neuropathy in primary health care setting. International Journal of Health Sciences 2012;6(2):127-34.
[11] Yang Z, Chen R, Zhang Y, Huang Y, Hong T, Sun F, et al. Scoring systems to screen for diabetic peripheral neuropathy. Cochrane Database of Systematic Reviews 2014;3.
[12] Dixit S, Maiya A. Diabetic peripheral neuropathy & its evaluation in a clinical scenario: a review. J Postgrad Med 2014;60(1):33-40.
[13] Bril V, Perkins B. Validation of the Toronto clinical scoring system for diabetic polyneuropathy. Diabetes Care 2002;25(11):2048-52.
[14] Pál E, Fülöp K, Tóth P, Deli G, Pfund Z, Janszky J, Komoly S. Small fiber neuropathy: clinicopathological correlations. Behavioural Neurology 2020;2020(1):8796519.
[15] Bril V, Tomioka S, Buchanan R, Perkins B. Reliability & validity of the modified Toronto Clinical Neuropathy Score in diabetic sensorimotor polyneuropathy. Diabetic Medicine 2009;26(3):240-6.
[16] Bril V, Hirose T, Tomioka S, Buchanan R. Ranirestat for the Management of Diabetic Sensorimotor Polyneuropathy. Diabetes Care 2009;32(7):1256-60.
[17] Bostani A, Homayuonfar H. The Relationship between NCS Findings & Toronto clinical scoring system of neuropathy in diabetic polyneuropathy. Journal of Kermanshah University of Medical Sciences 2006;10(3).
[18] Gill HK, Yadav SB, Ramesh V, Bhatia E. A prospective study of prevalence & association of peripheral neuropathy in Indian patients with newly diagnosed type 2 diabetes mellitus. J Postgrad Med 2014;60(3):270-75.
[19] Lauria G, Hsieh ST, Johansson O, Kennedy WR, Leger JM, Mellgren SI, et al. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies & the Peripheral Nerve Society. European Journal of Neurology 2010;17(7):903-e49.
[20] Gibbons CH, Griffin JW, Polydefkis M, Bonyhay I, Brown A, Hauer PE, et al. The utility of skin biopsy for prediction of progression in suspected small fiber neuropathy. Neurology 2006;66(2):256-8.
[21] Lauria G, Morbin M, Lombardi R, Borgna M, Mazzoleni G, Sghirlanzoni A, et al. Axonal swellings predict the degeneration of epidermal nerve fibers in painful neuropathies. Neurology 2003;61(5):631-6.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Dr. Nagender Devulapalli
Professor and HOD, Department of Internal Medicine, Apollo Institute of Medical sciences and Research, Hyderabad, Telangana, India.
Dr. Sireesha Nosina
Assistant Professor, Department of Internal Medicine, Apollo Institute of Medical sciences and Research, Hyderabad, Telangana, India.
Dr. Harshitha Bondugula
Associate Professor, Department of Dermatology, Apollo Institute of Medical sciences and Research, Hyderabad, Telangana, India.
Dr. Manohar Kandikatla
Professor and Dean, Department of General Medicine, Apollo Institute of Medical sciences and Research, Hyderabad, Telangana, India.
Dr. Humera Nausheen
Post Graduate, Department of General Medicine, Apollo Institute of Medical sciences and Research, Hyderabad, Telangana, India.
Dr Shashuveer Karippa
Post Graduate, Department of General Medicine, Apollo Institute of Medical sciences and Research, Hyderabad, Telangana, India.